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Abstract: Exposure to environmental pollutants is a global 
health problem and is associated with the development 
of many chronic diseases, including cardiovascular dis-
ease, diabetes and metabolic syndrome. There is a grow-
ing body of evidence that nutrition can both positively and 
negatively modulate the toxic effects of pollutant exposure. 
Diets high in proinflammatory fats, such as linoleic acid, 
can exacerbate pollutant toxicity, whereas diets rich in 
bioactive and anti-inflammatory food components, includ-
ing omega-3 fatty acids and polyphenols, can attenuate 
toxicant-associated inflammation. Previously, researchers 
have elucidated direct mechanisms of nutritional modu-
lation, including alteration of nuclear factor kappa-light-
chain-enhancer of activated B cells (NF-κB) signaling, but 
recently, increased focus has been given to the ways in 
which nutrition and pollutants affect epigenetics. Nutrition 
has been demonstrated to modulate epigenetic markers 
that have been linked either to increased disease risks or 
to protection against diseases. Overnutrition (i.e. obesity) 
and undernutrition (i.e. famine) have been observed to 
alter prenatal epigenetic tags that may increase the risk of 
offspring developing disease later in life. Conversely, bio-
active food components, including curcumin, have been 
shown to alter epigenetic markers that suppress the acti-
vation of NF-κB, thus reducing inflammatory responses. 
Exposure to pollutants also alters epigenetic markers and 
may contribute to inflammation and disease. It has been 
demonstrated that pollutants, via epigenetic modulations, 
can increase the activation of NF-κB and upregulate micro-
RNAs associated with inflammation, cardiac injury and oxi-
dative damage. Importantly, recent evidence suggests that 
nutritional components, including epigallocatechin gal-
late (EGCG), can protect against pollutant-induced inflam-
mation through epigenetic regulation of  proinflammatory 
target genes of NF-κB. Further research is needed to better 
understand how nutrition can modulate pollutant toxicity 
through epigenetic regulation. Therefore, the objective of 
this review is to elucidate the current evidence linking epi-
genetic changes to pollutant-induced diseases and how this 
regulation may be modulated by nutrients allowing for the 
development of future personalized lifestyle interventions.
Keywords: anti-inflammatory nutrients; antioxidant 
response; environmental pollutants; epigenetics; 
nutrition.
Introduction
The levels of environmental pollutants continue to rise 
worldwide, despite our increasing knowledge base of the 
negative health effects of pollutant exposure. There is 
increasing evidence that exposure to pollutants, including 
persistent organic pollutants (POPs), heavy metals and air 
pollution, can contribute to the progression of chronic 
diseases such as cardiovascular disease (CVD), diabetes 
and cancer. Currently, the strongest evidence linking POPs 
with inflammatory diseases is related to pollutant-induced 
diabetes (1, 2). Multiple meta-analyses show positive asso-
ciations of exposures to POPs such as polychlorinated 
biphenyls (PCBs) and pesticides with increased risk of 
developing type 2 diabetes (1, 2). The health effects of pol-
lutant exposure not only pose a problem for the individual 
but also contribute to the global burden of disease.
The mechanisms by which many of these pollutants 
contribute to disease involve an increase in cellular oxidative 
stress and subsequent inflammatory responses. For example, 
coplanar PCBs, a class of POPs, increase downstream inflam-
matory responses by binding to the aryl hydrocarbon receptor, 
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which can upregulate the transcription of cytochrome p450 
(Cyp1a1) (3, 4). Cyp1a1 is primarily involved in xenobiotic 
detoxification; however, in the presence of certain PCBs, it 
results in the production of reactive oxygen species (ROS) via 
an uncoupling mechanism (5). This production of ROS yields 
an increase in oxidative stress because of the imbalance in 
the cellular redox status (4). This pro-oxidative cellular status 
contributes to a state of chronic inflammation, which is a hall-
mark of many diseases, including atherosclerosis, diabetes 
and other metabolic disorders (6).
The most common routes of exposure to these envi-
ronmental pollutants are through inhalation of airborne 
pollutants as well as ingestion of contaminated foods (7). 
POPs, including PCBs and organochloride pesticides, are 
lipophilic and therefore readily accumulate in the tissue of 
living animals (8). Although the production of many of these 
pollutants has been banned, their resistance to degradation 
and stability in the environment have allowed for their bio-
accumulation throughout the ecosystem (8). Additionally, 
in humans, the accumulation of these lipophilic pollutants 
over the course of many years can lead to the activation of 
inflammatory pathways contributing to the development of 
numerous chronic inflammatory diseases (9, 10). Obesity is 
linked to higher pollutant body burden, but there is no con-
sensus if obesity makes a person more or less susceptible 
to pollutant-induced disease. Interestingly, there is some 
experimental evidence that points to the sequestration of 
pollutants in large adipose depots as actually being protec-
tive (11–13). Lipophilic pollutants may accumulate within 
adipocytes and lipid droplets, which limits their availabil-
ity to other target cell types. Importantly, it appears that 
obese individuals undergoing weight loss through either 
bariatric surgery or lifestyle intervention may be a highly 
susceptible population to pollutant-induced inflammation 
(11–13). Because overweight and obese individuals are not 
only capable of accumulating greater levels of pollutants 
but also already at an increased risk for developing chronic 
inflammatory diseases, dietary interventions that provide a 
means of combatting pollutant toxicity and chronic disease 
risk factors are of great importance. (8, 14, 15).
Nutrition as a modulator of 
pollutant toxicity
Poor nutrition can exacerbate the toxicity of 
pollutants
It is well established that exposure to environmen-
tal pollutants can increase risk of developing chronic 
inflammatory diseases, including CVD, diabetes, and 
metabolic syndrome (6–9). Additionally, evidence impli-
cates that individuals with a less nutritious or healthful 
diet (i.e. rich in processed foods and low in fruits and 
vegetables) are also at a greater risk of developing these 
same chronic diseases (16). Common to both pollutant 
exposure and poor nutrition is the activation of proin-
flammatory molecular proteins, including NF-κB, a key 
player in the development of inflammatory responses 
(17). Because of the overlap between pathways that 
mediate the negative effects of poor nutrition and 
environmental pollutants, there is an increasing body 
of experimental evidence demonstrating that certain 
nutritional components or overall nutritional status can 
exacerbate the negative health effects of environmental 
pollutant exposure.
Obesity is a global health problem and is a risk 
factor for the development of numerous inflammatory 
diseases (18). The rise in obesity is often attributed to 
overconsumption of processed, nutritionally poor foods 
(i.e. high energy density and low nutrient density) and 
foods high in proinflammatory fats (18). It has been 
consistently demonstrated that high fat diets, par-
ticularly those with greater proportions of fatty acids 
coming from saturated, trans, and linoleic fatty acids 
can increase inflammation and risk of CVD as well as 
other metabolic complications (19, 20). In addition to 
overconsumption of nutritionally poor foods, emerging 
evidence now links exposure to environmental pollut-
ants with increased adiposity and weight gain (21). Pol-
lutants that elicit this physiological effect are termed 
“obesogens” and are believed to contribute to obesity 
and metabolic disorder through promotion of chronic 
imbalances in lipid storage mechanisms and adipocyte 
hyperplasia (21). Current evidence suggests that pol-
lutant exposure can intensify the detrimental effects 
of a proinflammatory high-fat diet (22). For example, 
non-alcoholic fatty liver disease (NAFLD), commonly 
seen in developed countries as a hepatic indicator of 
obesity and metabolic syndrome, may be worsened by 
pollutant exposure. It has been demonstrated that the 
pollutant PCB153 exacerbates diet-induced obesity and 
NAFLD in mice through alterations in adipokines and 
disruptions in hepatic lipid metabolism (23). Addition-
ally, high-fat diets appear to worsen arsenic-induced 
liver fibrosis and inflammation (24), whereas diets high 
in saturated fat appear to increase the toxicity and car-
cinogenic effects of POPs (25). Furthermore, the flame 
retardant hexobromocyclododecane, was observed 
to enhance high-fat diet-induced obesity and hepatic 
steatosis and to impair glucose and lipid homeostasis 
in mice (26).
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Cardiovascular diseases (CVDs) are the leading cause 
of death worldwide, and it is estimated that approxi-
mately 90% of CVDs can be prevented (27). The primary 
modifiable risk factors contributing to the development of 
CVDs include poor dietary habits, physical inactivity, and 
smoking (27). Similarly, to the development of obesity, 
diets containing certain fatty acid profiles may promote 
the development of CVDs. For example, consumption of 
proinflammatory fatty acids such as linoleic and trans-
fatty acids can contribute to endothelial cell dysfunction, 
a beginning stage of atherosclerosis (19, 20). Addition-
ally, it has been demonstrated, primarily in experimental 
models, that exposure to environmental pollutants can 
cause endothelial cell dysfunction and chronic inflam-
mation and may contribute to the development of CVDs 
(3, 28, 29). Furthermore, there is increasing experimental 
evidence that poor nutrition and pollutant exposure can 
interact and synergistically increase CVD risk (30). For 
example, it has recently been shown that trimethylamine 
N-oxide (TMAO), produced from the metabolism of dietary 
carnitine or phosphatidyl choline, is a strong clinical bio-
marker of CVD (31–35). Interestingly, a recent preclinical 
paper from our group found that dioxin-like pollutant 
exposure increases the hepatic expression of the enzyme 
flavin-containing monooxygenase (FMO3), which is criti-
cal for the production of TMAO. As such, this increase 
in the hepatic expression of FMO3 resulted in increases 
in circulating TMAO (36). Although this study was con-
ducted in mice and the transcriptional regulation of FMO3 
could differ in humans, this finding is important in that 
it provides new evidence on how certain nutritional com-
ponents and pollutants may interact to contribute to a 
greater risk of CVD.
It is not surprising that pollutant exposure exhibits 
detrimental combinatory effects with suboptimal nutri-
tion as pollutants and nutritional components can target 
the same molecular pathways, for example, the proin-
flammatory NF-κB pathway (4). However, this same idea 
can be used from the perspective of nutrition as a pro-
tective modulator of pollutant toxicity and may be more 
meaningful for those already exposed to high levels of 
pollutants and exhibiting signs of chronic inflammatory 
diseases.
Healthful nutrition can protect against the 
health effects of pollutant exposure
It is well understood that a nutritious diet, rich in foods 
containing bioactive food components such as polyphe-
nols and anti-inflammatory fatty acids, can be protective 
against chronic inflammation, diabetes, metabolic syn-
drome, and CVD (16). Diets rich in these bioactive food 
components often contain greater levels of antioxidant 
and anti-inflammatory compounds and thus have the 
capacity to attenuate the inflammatory and oxidative 
properties of pollutant exposure. This paradigm has been 
demonstrated consistently throughout the literature (37–
43). For example, we have shown that consumption of 
polyphenol-rich green tea can decrease oxidative stress in 
response to PCB 126 exposure and does so via upregula-
tion of antioxidant enzymatic pathways (38). Additionally, 
it has been observed that epigallocatechin gallate (EGCG), 
a major polyphenol in green tea, can attenuate arsenic-
induced cardiovascular inflammation and toxicity (42). 
Resveratrol, a polyphenol found abundantly in fruits and 
other plants, has been demonstrated to protect against 
PCB-induced neuronal cell death as well as impairment in 
adipocyte glucose homeostasis (44, 45).
Omega-3 polyunsaturated fatty acids, including 
eicosapentaenoic acid and docosahexaenoic acid, found 
abundantly in fatty fish and fish oil, exhibit potent anti-
inflammatory properties (46, 47). Indeed, individuals con-
suming a diet abundant in omega-3 fatty acids, such as 
the well-studied Mediterranean diet, are documented as 
having lower incidences of CVD, diabetes, and metabolic 
syndrome (48). It is not surprising then, that experimental 
evidence shows that omega-3 fatty acids can be protec-
tive against pollutant-induced inflammation and toxicity. 
As such, we have demonstrated that omega-3 fatty acids 
can protect against PCB-induced vascular endothelial cell 
dysfunction (37), and others have shown that these fatty 
acids can protect against pollutant-associated atheroscle-
rotic plaque formation (49). Additionally, omega-3 fatty 
acids appear to be protective against air pollutant-asso-
ciated oxidative stress and cardiovascular complications 
by increasing the activity of endogenous antioxidants and 
decreasing lipoperoxidation (40, 43).
In addition to consuming a diet rich in polyphenols 
and anti-inflammatory components, choosing to live an 
active lifestyle may also protect against pollutant toxicity. 
For example, a recent study by our laboratory observed 
that exercise is capable of reducing inflammation and 
CVD risk associated with PCB exposure (50). Further-
more, other groups have demonstrated that exercise can 
attenuate PCB-associated alterations in the mouse gut 
microbiome (51). This is an important finding because 
the gut microbiome has recently been observed to regu-
late numerous health conditions, including obesity, CVD, 
immune function, and neurological disorders (52–54). 
Importantly, the gut microbiome is incredibly plastic and 
can change rapidly in response to nutrition, exercise, 
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and even pollutant exposure (52–54). Using nutrition 
and exercise to combat pollutant-induced alterations in 
the gut microbiome that may contribute to disease may 
allow for important advances in therapeutic interven-
tions and is a critical area of research that needs to be 
further explored.
Because many of these environmental pollutants 
are lipophilic and accumulate within the adipose tissue 
of exposed individuals, examining nutritional means to 
promote the excretion and reduction of body burden is an 
important facet as well. It has been noted that individu-
als consuming a vegetarian or vegan diet trended towards 
lower amounts of organochloride body burden (55). 
However, it remains unclear whether this observation 
was due to less exposure to contaminated foods (e.g. con-
taminated meats, fish, or dairy) or whether a plant-based 
diets contain nutritional components that can promote 
excretion of these pollutants. Although further research 
is still warranted to examine nutritional means by which 
to reduce pollutant body burden, some studies have indi-
cated promising opportunities for therapeutic interven-
tions in exposed individuals (56–58). Specifically, it has 
been observed that consumption of olestra, a dietary fat 
substitute, is effective at enhancing the excretion rate in 
individuals exposed to high concentrations of PCBs and 
is believed to do so through interference with the entero-
hepatic circulation of these pollutants (58–62). Because 
olestra is no longer in production due to decreased popu-
larity associated with adverse gastrointestinal side effects, 
there is a need for research examining other dietary com-
ponents that may alter enterohepatic circulation and/or 
enhance pollutant excretion. As discussed, it is well docu-
mented that nutrition and lifestyle choices can both posi-
tively and negatively regulate pollutant toxicity. Recently, 
the field of epigenetics has become important in further-
ing our understanding how environment and lifestyle 
choices differentially influence gene expression and may 
alter susceptibility to disease on an individual level.
Epigenetics as an emerging area 
of pollutant toxicity research and 
avenue for future intervention
Epigenetics overview
Epigenetics is a term given to describe all heritable 
changes in gene expression that do not involve changes 
within the genetic code (63). One of the most commonly 
studied means of epigenetic modifications is DNA meth-
ylation, which involves the addition of a methyl group 
to the five position of a cytosine. This modification most 
often occurs on a cytosine-guanine dinucleotide (CpG). 
CpG dinucleotides tend to be clustered in certain regions, 
termed CpG islands, and are often located in the promoter 
regions of protein-coding genes (63, 64). DNA methyla-
tion is involved in the regulation of numerous cellular 
processes, ranging from chromosome stability, to X-chro-
mosome inactivation, to gene transcription. Generally, 
the hypermethylation of CpG islands within the promoter 
regions results in gene silencing. Another common type 
of epigenetic alteration includes histone modifications. 
Histones are nuclear proteins that aid in the condensa-
tion of DNA into structural units called nucleosomes. 
Histones can undergo posttranslational modifications 
such as acetylation, methylation, and phosphorylation, 
which affect the interactions of histones with the DNA and 
associated nuclear proteins (63). Through these histone 
modifications, alterations in chromatin structure and 
subsequently gene expression are often observed (63, 64). 
A third major type of epigenetic modification involves 
microRNAs (miRNAs). miRNAs are small single-stranded 
noncoding RNA molecules that when fully mature lead to 
the degradation of target mRNA by direct binding. This 
downregulation of target mRNAs can ultimately lead to 
decreased protein production. miRNAs regulate numer-
ous biological processes, and it has been observed that 
alterations in miRNA expression are associated with the 
development of diseases such as CVD, metabolic disor-
ders and cancer (63–65).
Environment and lifestyle play critical roles in con-
tributing to the epigenetic alterations discussed above 
(65). Studies on monozygotic twin pairs have demon-
strated that throughout the aging process, identical twins 
develop differences in their epigenetic status despite their 
common genetic makeup (63). These observations and the 
knowledge that differences in epigenetic modifications 
can play a role in disease contributed to increasing inter-
est in examining the ways and extent to which our envi-
ronment influences our epigenetic code.
Epigenetics, environmental exposures and 
nutrition
It has been consistently demonstrated that exposure to 
environmental pollutants can influence epigenetic modi-
fications (65–69). Specifically, exposure to POPs can alter 
the epigenetic code through several mechanisms. For 
example, we have demonstrated that exposure to coplanar 
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PCBs, including PCB 77 and PCB126, can induce vascular 
endothelial cell dysfunction and inflammation through 
alterations in histone modifications of the p65  subunit 
of NF-κB that result in its increased activation (66). Addi-
tionally, we have shown that the commercial PCB mixture 
Aroclor 1260 can upregulate miRNAs associated with 
cardiac injury and inflammatory pathways in primary 
human endothelial cells (69). In humans, it has been 
observed that exposure to polyaromatic hydrocarbons 
(PAH) results in alterations in specific miRNAs associated 
with oxidative DNA damage and lipid peroxidation in coke 
oven workers (67). Moreover, it was noted that exposure to 
air pollution was associated with expression of miRNAs 
that may mediate detrimental biological responses and 
health effects (68).
One common theme with many pollutant-associ-
ated epigenetic alterations is that they induce modifica-
tions that contribute to proinflammatory and oxidative 
pathways (65, 70). Interestingly, nutrition and positive 
lifestyle choices can also contribute to epigenetic modi-
fications that may combat these detrimental effects by 
increasing antioxidant and anti-inflammatory responses 
(71, 72). Polyphenolic compounds found in many fruits 
and vegetables exhibit significant antioxidant and anti-
inflammatory capacities and thus are good candidates for 
studies examining epigenetic means of protection against 
pollutant toxicity. For example, curcumin, a component 
found in turmeric that exhibits anti-inflammatory prop-
erties, has been observed to reduce histone acetylation 
of the NF-κB coactivator p300  histone acetyltransferase 
and thus suppress the activation of NF-κB (73). Similar 
results were observed by our group with the tea catechin 
EGCG (74). Furthermore, it has been reported that numer-
ous polyphenols can activate SIRT1, a member of the 
sirtuin family of histone deacetylases. When activated, 
SIRT1 can participate in the deacetylation of transcrip-
tion factors such as NF-κB, forkhead box class O (FoxO) 
and p53, in turn modulating cellular pathways involved 
in inflammation, metabolism, aging, and several other 
conditions (71).
In addition to healthful nutrition, physical exercise 
also contributes to epigenetic modifications that may 
provide protection against metabolic, cardiovascular, and 
other diseases. For example, one study found that acute 
exercise resulted in changes in the methylation of the 
promoter region of genes involved in energy and glucose 
homeostasis, including pyruvate dehydrogenase kinase 
isoenzyme 4 (PDK4), peroxisome proliferator-activated 
receptor gamma coactivator 1-alpha (PCG1α), and peroxi-
some proliferator-activated receptor delta (PPARδ) within 
skeletal muscle (75). Furthermore, physical exercise was 
observed to inhibit the miRNA miR-33 (76, 77). Cellular 
effects of miR-33 inhibition involve the upregulation of 
AMPK and subsequent increases in β-oxidation, which 
may aid in balancing factors related to metabolic syn-
drome by increasing the breakdown of fatty acids from 
adipose stores (77). The role of β-oxidation in metabolic 
syndrome is complex and is influenced by both dietary 
components and exercise, leading to an increase in fatty 
acid oxidation and ultimately decreased obesity and 
metabolic syndrome (78–80). Understanding the role of 
miRNAs in lipid homeostasis may provide potential thera-
peutic strategies for reducing metabolic syndrome.
Although epigenetics can be modulated by healthful 
nutrition and positive lifestyle choices, there is also evi-
dence that epigenetics can be modified by poor nutrition. 
Epidemiological data are very helpful at examining epi-
genetic alterations, as there appears to be inheritance to 
specific DNA methylation patterns over generations. For 
example, it has been shown that individuals who were 
prenatally exposed to famine during the Dutch famine 
(1940s) had reduced DNA methylation of the insulin-like 
growth factor II (IGF2) gene six decades later, compared 
to their siblings who were unexposed to the famine (81). 
Also, it has been demonstrated that parental obesity can 
alter DNA methylation patterns in imprinted genes of their 
offspring, compared to offspring of nonobese parents, 
and this is believed to increase the risk for the develop-
ment of obesity and metabolic diseases later in life (82). 
Although there is still much to be studied about the effects 
of these alterations related to epigenetic modifications, it 
is hypothesized that in both cases of undernutrition and 
over-nutrition, the acquired epigenetic alterations may 
be passed down to the subsequent generation and may 
increase susceptibility to development of chronic diseases 
throughout life (81–83).
The epigenetic alterations in response to nutri-
tion and lifestyle choices have been well documented; 
however, studies examining the epigenetic effects of 
nutritional components on the modulation of pollut-
ant toxicity are limited. A recent study conducted by our 
group showed that EGCG, the most abundant polyphenol 
found in green tea, can prevent against PCB126-induced 
endothelial cell inflammation through epigenetic altera-
tions of proinflammatory target genes of NF-κB (74). This 
study was important in that it was one of the first studies 
to indicate the epigenetic role of healthful nutrition in the 
modulation of pollutant toxicity. Because of the gaps in 
the literature regarding epigenetic regulation of pollutant 
toxicity via nutritional and lifestyle interventions, there 
is a great need for further research to formulate a better 
understanding of this topic.
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Conclusion and future directions
Environmental pollutant exposure is associated with 
numerous health complications ranging from cardiovas-
cular disease, diabetes, and metabolic syndrome. There is 
evidence that pollutant toxicity can be modulated by nutri-
tion and lifestyle choices. Western diets, abundant in pro-
cessed foods, excess caloric content and proinflammatory 
fatty acids, may contribute to the development of obesity 
and, cardiovascular diseases and can enhance pollutant 
toxicity. Conversely, diets rich in bioactive food compo-
nents, such as polyphenols and omega-3 fatty acids (i.e. 
the Mediterranean diet), are associated with reduced risk 
of inflammatory diseases and can attenuate the negative 
health effects of pollutant exposure. Recently, epigenetics 
has become a focus of both nutrition and pollutant research 
and may provide a deeper mechanistic insight into how 
these two environmental factors can interact. It has been 
shown that both over- and undernutrition can contribute 
to epigenetic modifications that are associated with an 
increased risk of disease. Additionally, exposure to pollut-
ants can alter epigenetic markers that may also contribute 
to the development of health complications. Importantly, 
we have shown that bioactive food components (e.g. EGCG) 
can induce epigenetic alterations that attenuate inflamma-
tory responses associated with PCB exposure and thus may 
protect against the development atherosclerosis. Epige-
netic marks differ for every individual, and therefore future 
studies may allow us to understand how certain foods may 
be used to alter specific epigenetic tags to reduce the risk 
of pollutant-associated disease. Future studies also need to 
focus on metabolites of both pollutants and nutrients and 
the complex interplay of epigenetic regulation of chronic 
diseases. Fostering an understanding at this detailed level 
could help in developing personalized nutritional interven-
tions that could epigenetically favor good health and thus 
reduce the risk of disease.
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